CD4 and neoplasm: In two previous studies47,48, MHC-II expression on tumor cells by immunohistochemistry was found to be predictive for response to anti-PD1 ICB and was hypothesized to represent a subset of tumors that could stimulate CD4+ helper T cell or cytotoxic activity.